Sonja Schrepfer

Title: The Innovative Contributions of Sonja Schrepfer

Introduction

Sonja Schrepfer is a prominent inventor based in San Mateo, California. She has made significant contributions to the field of biotechnology, particularly in the development of engineered cells for therapeutic applications. With a total of three patents to her name, her work is paving the way for advancements in CAR-T cell therapy.

Latest Patents

One of her latest patents focuses on methods and compositions for modulating CAR-T activity. This patent discloses engineered cells and hypoimmunogenic cells, including engineered stem cells and CAR-T cells. These cells exhibit reduced expression of MHC class I and II human leukocyte antigens and T-cell receptors. Additionally, some embodiments of these cells exogenously express tolerogenic factors such as CD47 and chimeric antigen receptors (CARs). This innovative approach aims to enhance the efficacy and safety of CAR-T therapies.

Career Highlights

Sonja Schrepfer is currently associated with Sana Biotechnology, Inc., where she continues to push the boundaries of scientific research. Her work is instrumental in developing new therapeutic strategies that could potentially transform cancer treatment.

Collaborations

Throughout her career, Sonja has collaborated with notable colleagues, including Lindong Weng and Terry J Fry. These partnerships have further enriched her research and contributed to the advancement of her innovative projects.

Conclusion

Sonja Schrepfer's contributions to biotechnology and her innovative patents in CAR-T cell therapy highlight her role as a leading inventor in her field. Her work not only showcases her expertise but also holds promise for future advancements in medical treatments.